MacroGenics
MGNX
#8365
Rank
NZ$0.49 B
Marketcap
NZ$7.79
Share price
5.09%
Change (1 day)
218.08%
Change (1 year)

EPS for MacroGenics (MGNX)

EPS in 2026 (TTM): NZ-$2.62

According to MacroGenics's latest financial reports the company's current EPS (TTM) is NZ-$2.63. In 2025 the company made an earnings per share (EPS) of NZ-$2.03 a decrease over its 2024 EPS that were of NZ-$1.84.

EPS history for MacroGenics from 2011 to 2026

Annual EPS

Year EPS Change
2026 (TTM)NZ-$2.6229.53%
2025NZ-$2.0310.28%
2024NZ-$1.84613.33%
2023NZ-$0.26-92.31%
2022NZ-$3.35-42.14%
2021NZ-$5.7836.44%
2020NZ-$4.24-21.84%
2019NZ-$5.42-24.58%
2018NZ-$7.19675.93%
2017NZ-$0.93-68.05%
2016NZ-$2.90168.25%
2015NZ-$1.08-55%
2014NZ-$2.403400%
2013NZ-$0.06866-108.68%
2012NZ$0.7924.49%
2011NZ$0.64

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Pfizer
PFE
NZ$2.25-185.62%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
NZ$48.45-1,944.79%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
NZ$24.85-1,046.41%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
NZ$12.74-584.97%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
NZ$6.14-333.65%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
NZ$6.11-332.68%๐Ÿ‡บ๐Ÿ‡ธ USA
Xencor
XNCR
NZ-$3.93 49.67%๐Ÿ‡บ๐Ÿ‡ธ USA